These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, report not yet due Terminated 2012-003810-15 Pazopanib versus Pazopanib plus Gemcitabine in patients with relapsed or metastatic uterine leiomyosarcomas or other uterine tumour: a multi-center, randomized phase-II clinical trial of the NOGGO and... 2024-02-14 not-yet-due
Not reported Terminated 2016-005029-36 Comparison of QoL between Trabectedin / PLD and standard platinum-based therapy in patients with platinum sensitive recurrent ovarian, fallopian tube and peritoneal cancer - Intergroup-Study of NOGGO ... 2023-08-08 due-trials
Completed, report not yet due Terminated 2019-000399-41 Rucaparib MAintenance after Bevacizumab Maintenance following Carboplatin based first line chemotherapy in Ovarian Cancer patients Rucaparib Erhaltungstherapie nach Bevacizumab-Therapie und Carbop... 2023-12-01 not-yet-due
Other 2020-004083-25 Phase II investigational study of pembrolizumab combination with chemotherapy in platinum-sensitive recurrent low-grade serous ovarian cancer Phase-II-Studie zu Pembrolizumab in Kombination mit ein... not-yet-due